Opioids News

News

BEDMINSTER, N.J., Dec. 30, 2011 /PRNewswire/ -- ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin...
www.biospace.com | Jan 3, 2012
BEDMINSTER, N.J., Dec. 30, 2011 /PRNewswire/ -- ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd. , and an international specialty

Pain Therapeutics - Drugs, Markets and Companies | SYS-CON MEDIA
www.sys-con.com | Dec 29, 2011
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.

Retail Speculators Getting Amped On Ampio Pharmaceuticals - Seeking Alpha
seekingalpha.com | Dec 14, 2011
< strong > By < a href='http://primostocks.wordpress.com/' > Adam Gefvert < /a > : < /strong > < p > Basically, Ampion Pharmaceuticals ( < a href='http://seekingalpha.com/symbol/ampe' title='Ampio Pharmaceuticals, Inc. ' > AMPE < /a > ) is a group of a few executives who sit around and try to think

amednews: States try more aggressive Rx opioid controls :: Oct. 17, 2011 ... American Medical News
www.ama-assn.org | Oct 17, 2011
Stricter oversight of physicians includes setting dosage limits and requiring CME.

ReportsnReports- Opioids Market to 2017 - Steady Uptake of Oxycontin | PRLog
www.prlog.org | Jun 27, 2011
ReportsnReports- Opioids Market to 2017 - Steady Uptake of Oxycontin. ReportsnReports adds GBI Research’s ‘Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market’ to its store. - PR11560092

New Narcotics Safe, Medixsafe, Protects Medics from Addiction and Blame
www.prweb.com | Jun 14, 2011
By Creating an Electronic Audit Trail, Medixsafe™ Offers Accountability and Security with New Narcotics Safe.

Medical News: Causes of Increase in Opioid Deaths Probed - in Psychiatry, Addictions from MedPage
www.medpagetoday.com | Jun 13, 2011
Methadone appears to be involved in a large proportion of opioid-related deaths in the U.S., researchers found.

Codeine risks for elderly patients
www.6minutes.com.au | Dec 15, 2010
Concerns have been raised over the safety of opioids for treating non-cancer pain in elderly people after researchers found they increase the risk of fractures and death compared with other analgesics.

Potential drug therapy for diabetic retinopathy under study
www.eurekalert.org | Nov 9, 2010
One drug's startling ability to restore retinal health in the eyes of diabetic mice has researchers wanting to learn more about how it works and whether it might do the same for people. "We want to know if this drug has the potential to block the visual devastation that can occur with diabetes,"

Frost & Sullivan Recognizes QRxPharma for Innovative Pain Relief Product MoxDuo
www.frost.com | Aug 17, 2010
Based on its recent analysis of the opioid pain management market, Frost & Sullivan recognizes QRxPharma Limited with the 2010 North American Frost & Sullivan Award for New Product Innovation of the Year for MoxDuo® immediate-release (IR) (Q8003IR) – the first patented dual opioid for the